Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 749

The DOI matches its Crossref record; 190 of the 190 references it cites were found in a registry or an index.

The future of cancer immunotherapy: microenvironment-targeting combinations

Open access
Murciano-Goroff, Yonina R., Warner, Allison Betof, Wolchok, Jedd D.·2020·Cell Research

Abstract

Immunotherapy holds the potential to induce durable responses, but only a minority of patients currently respond. The etiologies of primary and secondary resistance to immunotherapy are multifaceted, deriving not only from tumor intrinsic factors, but also from the complex interplay between cancer and its microenvironment. In addressing frontiers in clinical immunotherapy, we describe two categories of approaches to the design of novel drugs and combination therapies: the first involves direct modification of the tumor, while the second indirectly enhances immunogenicity through alteration of the microenvironment. By systematically addressing the factors that mediate resistance, we are able to identify mechanistically-driven novel approaches to improve immunotherapy outcomes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41422-020-0337-2

Cites

190 of 190 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 190 references

Cited by

See all 749

Metadata

Authors
Murciano-Goroff, Y. R., Warner, A. B., & Wolchok, J. D.
Venue
Cell Research
Published
2020-05-28
Volume
30
Issue
6
Pages
507-519
ISSN
  • 1001-0602 (ISSN-L)
  • 1748-7838
OpenAlex
W3031508706
Cited by
749
References
190
FWCI
37.13
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The future of cancer immunotherapy: microenvironment-targeting combinations. https://app.cochat.ai/papers/10.1038/s41422-020-0337-2
The paper
Murciano-Goroff, Y. R., Warner, A. B., & Wolchok, J. D. (2020). The future of cancer immunotherapy: microenvironment-targeting combinations. Cell Research. https://doi.org/10.1038/s41422-020-0337-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.